Corcept Therapeutics files Form 144 to sell 20,000 shares

Corcept Therapeutics Inc. files a Form 144 reporting an intended sale of 20,000 shares of Common Stock through Stifel Nicolaus & Company Inc. on 05/05/2026 via a stock option exercise for cash.

Rhea-AI Filing Summary

Corcept Therapeutics Inc. files a Form 144 reporting an intended sale of 20,000 shares of Common Stock through Stifel Nicolaus & Company Inc. on 05/05/2026 via a stock option exercise for cash. The filing also lists three prior dispositions by William Guyer on 03/04/2026, 03/20/2026, and 04/08/2026 totaling 40,000 shares reported with dollar amounts alongside each sale.

Insights

Equity Capital Markets Analyst

Form 144 reports an affiliate sale of 20,000 shares via brokered exercise-and-sale.

The filing lists a proposed sale of 20,000 shares through Stifel Nicolaus on 05/05/2026, identified as a stock option exercise settled for cash. Prior dispositions by the same reporting person are listed with dates and proceeds.

Cash‑flow treatment is explicit for the exercise (cash). Timing and aggregate impact on outstanding share count are not provided in the excerpt; subsequent filings may show final trade settlement and any changes in post-transaction holdings.

Key Figures

Proposed shares to be sold: 20,000 shares Reported proceeds (line item): $1,032,000.00 Prior sale on 04/08/2026: 20,000 shares +2 more

5 metrics

Proposed shares to be sold 20,000 shares planned sale through Stifel Nicolaus on 05/05/2026

Reported proceeds (line item) $1,032,000.00 appears on same line as broker and 20,000 (from excerpt)

Prior sale on 04/08/2026 20,000 shares William Guyer disposition reported with $819,453.00

Prior sale on 03/20/2026 11,767 shares William Guyer disposition reported with $423,707.00

Prior sale on 03/04/2026 8,233 shares William Guyer disposition reported with $296,346.00

Key Terms

Form 144, stock option exercise, proposed disposition

3 terms

Form 144 regulatory

"files a Form 144 reporting an intended sale"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

stock option exercise financial

"described as a stock option exercise for cash"

A stock option exercise is the act of using a previously granted right to buy shares of a company's stock at a specific, predetermined price by paying that price and receiving the shares. It matters to investors because exercising changes who owns the shares (which can dilute existing ownership), can trigger taxable events and shift potential gains or losses, and affects voting power and the company’s outstanding share count—like turning a voucher into an actual product that becomes part of circulating supply.

proposed disposition regulatory

"Securities To Be Sold Common 05/05/2026 Stock Option Exercise"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does Corcept Therapeutics' Form 144 (CORT) report?

It reports a proposed sale of 20,000 shares. The sale is through Stifel Nicolaus on 05/05/2026 and is described as a stock option exercise settled in cash.

Who is the reporting person in the Form 144 for CORT?

William Guyer is named in the filing. The excerpt lists multiple prior dispositions by Guyer on 03/04/2026, 03/20/2026, and 04/08/2026 with share counts and proceeds.

How many shares were proposed and what broker is handling the sale in the CORT filing?

20,000 shares are proposed for sale. The broker shown is Stifel Nicolaus & Company Inc. and the transaction method is a stock option exercise for cash on 05/05/2026.

What prior sales by the reporting person are listed in the Form 144 excerpt?

Three prior dispositions are listed. They are: 03/04/2026 for 8,233 shares ($296,346), 03/20/2026 for 11,767 shares ($423,707), and 04/08/2026 for 20,000 shares ($819,453).

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 05/05/2026 - 11:13 AM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001879013
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	CORCEPT THERAPEUTICS INC
SEC File Number	000-50679
Address of Issuer	101 REDWOOD SHORES PARKWAY REDWOOD CITY CALIFORNIA 94065
Phone	650.688.8803
Name of Person for Whose Account the Securities are To Be Sold	Guyer William
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Stifel Nicolaus & Company Inc. 501 N. Broadway St. Louis MO 63102	20000	1032000.00	107350000	05/05/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	05/05/2026	Stock Option Exercise	Corcept Therapeutics Inc.			20000	05/05/2026	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
William Guyer 101 Redwood Shores Parkway Redwood City CA 94065	Common	04/08/2026	20000	819453.00
William Guyer 101 Redwood Shores Parkway Redwood City CA 94065	Common	03/04/2026	8233	296346.00
William Guyer 101 Redwood Shores Parkway Redwood City CA 94065	Common	03/20/2026	11767	423707.00

144: Remarks and Signature

Remarks
Date of Notice	05/05/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	11/27/2024
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Toni Dobel, as a duly authorized representative of STIFEL, as attorney-in-fact for William Guyer
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)